Friday, March 3, 2017

Oncogene - Table of Contents alert Volume 36 Issue 9

If you are unable to see the message below, click here to view.


Specific CRISPR/Cas9/Cpf1 antibodies for clean and reliable results

  • Validated for chromatin immunoprecipiation, IP, IF, Western blots
  • Available from S. pyogenes and S. aureus raised against the N- or C-terminus
  • Polyclonal and monoclonal 

Learn more about our large collection of verified Cas9 and Cpf1 antibodies 


Volume 36, Issue 9 (March 2017)

In this issue
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



Hotspots of MLV integration in the hematopoietic tumor genome OPEN

T Tsuruyama, T Hiratsuka and N Yamada

Oncogene 2017 36: 1169-1175; advance online publication, November 7, 2016; 10.1038/onc.2016.285

Abstract | Full Text

The role of claudins in cancer metastasis

S Tabariès and P M Siegel

Oncogene 2017 36: 1176-1190; advance online publication, August 15, 2016; 10.1038/onc.2016.289

Abstract | Full Text

Original Articles


The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration

K Matsumura, Y Kawasaki, M Miyamoto, Y Kamoshida, J Nakamura, L Negishi, S Suda and T Akiyama

Oncogene 2017 36: 1191-1199; advance online publication, October 31, 2016; 10.1038/onc.2016.282

Abstract | Full Text

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort

M Apicella, C Migliore, T Capelôa, S Menegon, M Cargnelutti, M Degiuli, A Sapino, A Sottile, I Sarotto, L Casorzo, P Cassoni, M De Simone, P M Comoglio, S Marsoni, S Corso and S Giordano

Oncogene 2017 36: 1200-1210; advance online publication, August 15, 2016; 10.1038/onc.2016.283

Abstract | Full Text

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients OPEN

S Lefort, A Thuleau, Y Kieffer, P Sirven, I Bieche, E Marangoni, A Vincent-Salomon and F Mechta-Grigoriou

Oncogene 2017 36: 1211-1222; advance online publication, September 26, 2016; 10.1038/onc.2016.284

Abstract | Full Text

Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth OPEN

X Deng, G Shao, H-T Zhang, C Li, D Zhang, L Cheng, B D Elzey, R Pili, T L Ratliff, J Huang and C-D Hu

Oncogene 2017 36: 1223-1231; advance online publication, August 22, 2016; 10.1038/onc.2016.287

Abstract | Full Text

Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma

S Murakami, D Shahbazian, R Surana, W Zhang, H Chen, G T Graham, S M White, L M Weiner and C Yi

Oncogene 2017 36: 1232-1244; advance online publication, August 22, 2016; 10.1038/onc.2016.288

Abstract | Full Text

LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism

Q Zeng, J Chen, Y Li, K D Werle, R-X Zhao, C-S Quan, Y-S Wang, Y-X Zhai, J-W Wang, M Youssef, R Cui, J Liang, N Genovese, L T Chow, Y-L Li and Z-X Xu

Oncogene 2017 36: 1245-1255; advance online publication, August 22, 2016; 10.1038/onc.2016.290

Abstract | Full Text

The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms OPEN

Y-X Jiang, S-W Yang, P-A Li, X Luo, Z-Y Li, Y-X Hao and P-W Yu

Oncogene 2017 36: 1256-1264; advance online publication, August 15, 2016; 10.1038/onc.2016.291

Abstract | Full Text

Aurora A kinase activates YAP signaling in triple-negative breast cancer

S-S Chang, H Yamaguchi, W Xia, S-O Lim, Y Khotskaya, Y Wu, W-C Chang, Q Liu and M-C Hung

Oncogene 2017 36: 1265-1275; advance online publication, September 5, 2016; 10.1038/onc.2016.292

Abstract | Full Text

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells OPEN

K Tominaga, T Shimamura, N Kimura, T Murayama, D Matsubara, H Kanauchi, A Niida, S Shimizu, K Nishioka, E-i Tsuji, M Yano, S Sugano, Y Shimono, H Ishii, H Saya, M Mori, K Akashi, K-i Tada, T Ogawa, A Tojo, S Miyano and N Gotoh

Oncogene 2017 36: 1276-1286; advance online publication, August 22, 2016; 10.1038/onc.2016.293

Abstract | Full Text

Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming

O A Romero, S Verdura, M Torres-Diz, A Gomez, S Moran, E Condom, M Esteller, A Villanueva and M Sanchez-Cespedes

Oncogene 2017 36: 1287-1296; advance online publication, September 5, 2016; 10.1038/onc.2016.296

Abstract | Full Text

RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways

L Zhang, P Wang, Y Qin, Q Cong, C Shao, Z Du, X Ni, P Li and K Ding

Oncogene 2017 36: 1297-1308; advance online publication, September 12, 2016; 10.1038/onc.2016.306

Abstract | Full Text

Short Communication


Sustained p16INK4a expression is required to prevent IR-induced tumorigenesis in mice

L Palacio, V Krishnan, N L O Le, N E Sharpless and C M Beauséjour

Oncogene 2017 36: 1309-1314; advance online publication, August 29, 2016; 10.1038/onc.2016.298

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: